APA (7th ed.) Citation

E, M., A, H., & M, S. (2022). [Multimodality treatment in high-risk and very high-risk prostate cancer: Outcomes from international phase III randomized controlled trials]. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 198(10), 962. https://doi.org/10.1007/s00066-022-01968-5

Chicago Style (17th ed.) Citation

E, Mathier, Heusel A, and Shelan M. "[Multimodality Treatment in High-risk and Very High-risk Prostate Cancer: Outcomes from International Phase III Randomized Controlled Trials]." Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [et Al] 198, no. 10 (2022): 962. https://doi.org/10.1007/s00066-022-01968-5.

MLA (9th ed.) Citation

E, Mathier, et al. "[Multimodality Treatment in High-risk and Very High-risk Prostate Cancer: Outcomes from International Phase III Randomized Controlled Trials]." Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [et Al], vol. 198, no. 10, 2022, p. 962, https://doi.org/10.1007/s00066-022-01968-5.